ArticleThe Lancet regional health. Europe2026

Immunoadsorption Versus Sham Treatment for Post-COVID Syndrome: A Randomised Sham-Controlled Crossover Trial.

Marco Stortz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.